Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic SclerosisJacob M. van Laar, A Tyndall, Stefan M. Weiner et al.|JAMA|2014Cited by 739
The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositisAlexander Oldroyd, Dennis McGonagle, Jamie C. Sergeant et al.|Lara D. Veeken|2018Cited by 110
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan McCarthy, Emily Sutton, Stephanie Nesbit et al.|Lara D. Veeken|2017Cited by 94
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scopeMd Yuzaiful Md Yusof, Edward M Vital, Eve Smith et al.|Rheumatology Advances in Practice|2023Cited by 8
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan Malcolm Hum, Ann Brownfield, Pauline Ho et al.|Lara D. Veeken|2022Cited by 8